Literature DB >> 7051971

Susceptibility of Nocardia asteroides to various antibiotics, including newer beta-lactams, trimethoprim-sulfamethoxazole, amikacin, and N-formimidoyl thienamycin.

M E Gombert.   

Abstract

The susceptibility of 26 isolates of Nocardia asteroides to several antibiotics was determined by the agar dilution technique. Many currently available beta-lactam antibiotics were ineffective. Cefotaxime, cefmenoxime, and N-formimidoyl thienamycin were active against these strains, with 80% minimal inhibitory concentrations of 4, 4, and 2 micrograms/ml, respectively. Amikacin was the most effective agent tested.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7051971      PMCID： PMC182064          DOI： 10.1128/AAC.21.6.1011

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  4 in total

1.  Nocardia asteroides; studies of its pathogenicity and drug sensitivities.

Authors:  E H RUNYON
Journal:  J Lab Clin Med       Date:  1951-05

2.  In vitro susceptibility of Nocardia asteroides to amikacin.

Authors:  J R Dalovisio; G A Pankey
Journal:  Antimicrob Agents Chemother       Date:  1978-01       Impact factor: 5.191

3.  Activity of minocycline against Nocardia asteroides: comparison with tetracycline in agar-dilution and standard disc-diffusion tests and with sulfadiazine in an experimental infection of mice.

Authors:  M C Bach; O Gold; M Finland
Journal:  J Lab Clin Med       Date:  1973-05

4.  In vitro studies of the combined effect of ampicillin and sulfonamides on Nocardia asteroides and results of therapy in four patients.

Authors:  M G Orfanakis; H G Wilcox; C B Smith
Journal:  Antimicrob Agents Chemother       Date:  1972-03       Impact factor: 5.191
  4 in total
  18 in total

1.  Antimicrobial susceptibility patterns of Nocardia asteroides.

Authors:  R J Wallace; L C Steele; G Sumter; J M Smith
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

2.  Modified Thayer-Martin medium for recovery of Nocardia species from contaminated specimens.

Authors:  P R Murray; A C Niles; R L Heeren
Journal:  J Clin Microbiol       Date:  1988-06       Impact factor: 5.948

3.  Susceptibility of Nocardia asteroides to new quinolones and beta-lactams.

Authors:  M E Gombert; T M Aulicino; L duBouchet; L R Berkowitz
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  In vitro susceptibilities of Nocardia species to newer antimicrobial agents.

Authors:  P Berkey; D Moore; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

Review 5.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

6.  Organisms designated as Nocardia asteroides drug pattern type VI are members of the species Nocardia cyriacigeorgica.

Authors:  Patricia S Conville; Frank G Witebsky
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

7.  In vitro antimicrobial susceptibilities of Nocardia species.

Authors:  N Khardori; R Shawar; R Gupta; B Rosenbaum; K Rolston
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191

8.  Therapy of experimental cerebral nocardiosis with imipenem, amikacin, trimethoprim-sulfamethoxazole, and minocycline.

Authors:  M E Gombert; T M Aulicino; L duBouchet; G E Silverman; W M Sheinbaum
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

Review 9.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

10.  Therapy of pulmonary nocardiosis in immunocompromised mice.

Authors:  M E Gombert; L B Berkowitz; T M Aulicino; L duBouchet
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.